We are touched by the stories of the people who are treated with our stents. We go above and beyond to make sure they receive our lifesaving products when it matters most. Surgeons around the world value Bentley‘s impressive combination of high quality, reliable services and exceptional commitment from every single employee.
Bentley’s entrepreneurial team has positioned us as the European market leader in covered stents substituting open surgery. We are propelled by the megatrend of an aging population that increasingly requires endovascular treatment of aortic and peripheral diseases. We are delighted to have Keensight Capital join us on our growth journey and support us in our go-to-market strategy in the US. We are also very pleased to have A.P. Møller Holding and Bonit Capital on board. It’s great to find this high esteem of the financial community for our innovation-driven business and the achievements of our committed employees. The continued strong position of the founders and management will secure our position as an independent player. The stage is set. I firmly believe that our success will continue for many years to come.
Sebastian Büchert, CEO